biogenist_top_1




A Scientific Approach To Biotechnology

biogenist_Banner_under_links
A Scientific approch to biotechnology between_pic_1 Biotechnology between_pic_2 Biotechnology Help
biogenist_divider_hor
 

Understanding Biotechnology


What is Biotechnology

Overview of Biotechnology

  Then and Now of Biotechnology
 

History of Biotechnology

  Gene Technology
  What is a gene
  Gene Technology Techniques
  Genetic modification myths
  Genes code for proteins
  What is DNA
  Where is DNA
  The Full Set
  What does DNA look like
  What does DNA work
  DNA Unknown

Why do we do biotechnology?


  Why do we do biotechnology?
  Biotechnology for ourselves

Biotechnology for the environment

Biotechnology for food and agriculture

How do you do biotechnology?

  How do you do biotechnology
Finding the gene you want
  Cutting and pasting genes
  Moving genes
  Reading and interpreting genes
  Cloning a gene
  Cloning plants
  Cloning animals
Biotechnology Applications

  Human Uses
  Fighting infectious diseases
  Antibiotics
  Producing human products
  Reproductive technologies
  The human genome project
  Genetic disorders
  Gene therapy
  Cloning
  Stem cells
  Transplantation
  DNA profiling
  Environment
  Biological control of pests
  Protecting threatened species
  Resurrecting extinct species
  Cleaning up and managing
  Researching new products
  Food and Agriculture
  Feed Me
  A problem with weeds
  A problem with insects
  Other reasons to modify crops
  The international scene
  Genetically modified food labeling
  Health and Medical
  Biotechnology in medicines
  Clinical trials
  Gene therapy
  Genes and cancer
  What are ethics
Benefits & Risks of Biotechnology

  Arguments for and against gene
  A nutritionist's view on GM foods
  Balance sheet 2020
  Sustaining the Food supply
Biotechnology Resources

  Ethics of biotechnology
  Conferences and events
  Forums and Communities
  Biotechnology Websites
  Glossary of terms
   
 
 

 

  Bookmark and Share

 

Transplantation

  Transplanting living tissue from person to person is a standard surgical procedure.

Successful organ transplants between humans have created an increased demand for donor organs. This demand has vastly outgrown the supply of organs available.

Closing the gap between supply and demand is not easy. The tissue of the donor and the recipient need to be compatible, so that rejection does not occur. The tissue also needs to be collected in a strict medical environment.

Around half of all people who need a transplant die while on waiting lists. The need for organs and tissues for transplantation increases the pressure on researchers to find other ways of providing the needed tissues.

Other ways of providing tissues include using:

  • human cells in tissue culture
  • embryonic or other stem cells to grow new cell types.

Tissue culture is the term used to describe growing specialised human cells such as skin, blood and ligament cells in the laboratory. Tissue culture is a very important method of providing healthy tissue for transplantation. It is a very useful technique, because the tissue produced has developed from a patient's own cells; the body may try to reject cells from a different person.

For more than 25 years, skin cells have been cloned to produce healthy skin for people who require skin grafts after burns or accidents. Healthy cells are removed from the person who requires the cultured tissue, separated, placed in a container of liquid nutrients and kept under conditions that enable them to multiply.

Specialised adult cells can also be cloned in this way, but they usually stop dividing after about 20 cell divisions. Therefore, with current technology, very large patches of skin cannot be produced.

Increased understanding of the mechanisms of transplant organ rejection means that organs from other species may soon be used as an alternative to human tissues to help alleviate organ shortages.

 
 

Transplants from animals

  Transplantation from one species to another is called xenotransplantation. For people, it’s called animal-to-human transplantation.

In 2004, the National Health and Medical Research Council decided to stop animal-to-human clinical trials for five years. If it is allowed to go ahead after that time, pigs will be the preferred donor animal for use in humans, because their organs are so similar to ours. The pigs would be genetically modified so that their cells, tissues and organs would be less likely to be rejected when transplanted into humans.

Other experimental procedures aim to use xenografts (cells or tissues transplanted from other species) to treat illnesses such as AIDS, cancer, diabetes and Parkinson's disease.

The first recorded instance of xenotransplantation was in 1682. Part of a dog’s skull was used to repair the broken skull of a Russian nobleman. The first successful organ xenotransplant occurred in 1963. Chimpanzee kidneys were transplanted into 13 patients; however, only one survived more than nine months. The first heart xenotransplant occurred in 1964, using a chimpanzee heart. In 1984, baby Fae received a baboon heart and lived for 21 days. In addition to primates, organs for xenotransplantation have been taken from pigs and sheep.

Concerns regarding xenotransplantation include:

  • transplant tissue may carry unknown, latent (hidden) infections; when introduced into the recipient, these could be activated and lead to infection
  • previously animal-specific infections could become pathogenic to humans.

Work is underway to assess the extent of these risks

 
 

What do others think?

  During 2002-2004, a number of community forums discussed animal-to-human transplantation. These forums were hosted by the National Health and Medical Research Council (NHMRC), the government organisation responsible for looking at ethical considerations in research.

In 2004, after public consultation, the NHMRC produced a report about whether or not clinical trials into animal-to-human transplantation therapies should proceed in Australia.

This report details the considerable feeling in the community against animal-to-human transplantation. Some of the concerns include:

  • the risk of introducing new diseases from animals to humans
  • ethical and social concerns about the welfare of the animals used
  • doubts about the benefits to the patient and whether these outweigh the risks
  • that there is a need for more regulation before proceeding further
  • that funds and resources would be better spent in other areas of medicine.

In response to these concerns, the NHMRC announced that there should be a five-year moratorium - until 2009 - on any clinical research into animal-to-human whole organ transplants in Australia.

The NHMRC has ruled that non-human primates, such as baboons, should never be considered as source animals for any future clinical trials of animal-to-human transplantation. It also requested more time to consider other animal-to-human transplantation therapies.

   
 
   
biogenist_Bottom